Abstract: High-density composites of alumina and titania with nano-sized grains are prepared from aluminum titanate without the need to use nano-sized powder as a starting material. The preparation is achieved by high-energy ball milling of the aluminum titanate followed by sintering at elevated temperature and pressure. The aluminum titanate can be prepared from micron-sized alumina and titania particles through plasma jet processing.

Abstract: A method of producing tight bezel fits between automotive interior panels and their mating subcomponents. The method includes forming at laminate preform, injection molding a substrate layer behind the laminate preform to form a molded automotive interior panel, and forming an opening in the molded automotive interior panel. The method further includes post embossing the molded automotive interior panel adjacent a perimeter of the opening to produce an embossed interface between the molded automotive interior panel and a mating subcomponent installed in the opening, thereby producing a tight bezel fit between the molded automotive interior panel and the mating subcomponent installed in the opening. Alternatively, the method includes utilizing a vacuum wrapped automotive interior panel with the embossing step described above. The invention also provides for an automotive interior panel including a tight bezel fit between the panel and mating subcomponents, formed by the aforementioned methods.

Abstract: The present invention provides a method in which a strengthened platinum material can be produced, in which no blisters occur on the surface of the material even after heat treatment of 1,400° C. or higher and a metal oxide such as zirconium oxide is finely dispersed, and which has excellent high-temperature creep properties, when the strengthened platinum material is produced using a melt-sprayed platinum alloy powder. The method for producing a strengthened platinum material includes oxidizing a platinum alloy powder obtained by melt-spray, wet-milling the platinum alloy powder by adding an organic solvent, sintering, and forging, wherein the wet-milled platinum alloy fine powder is charged into a heat resistant container and heated to 1,200 to 1,400° C. in a vacuum atmosphere to be subjected to degassing.

Abstract: Articles formed from powders containing tungsten and at least one binder. In some embodiments, the article contains at least one metallic binder. In some embodiments, the article contains at least one non-metallic binder, such as a polymeric binder. In some embodiments, the article contains both a metallic binder and a non-metallic binder. In some embodiments the article is a firearms projectile, such as a bullet or shot, which may be ferromagnetic or non-ferromagnetic, which may be frangible or infrangible, and which may be jacketed or unjacketed. In some embodiments, the article is a radiation shield, and in other embodiments, the article is a weight or foundry article. In some embodiments, the article has a density in the range of approximately 8 g/cc and approximately 15 g/cc.

Abstract: The present invention relates to a method of fabricating ultra-fine grain cermet alloys with a homogenous solid solution grain structure. More particularly, the invention relates to a method of fabricating an ultra-fine TiC-base cermet alloy with a homogenous solid solution structure which does not comprise a core-rim structure in the carbide grain. The object of the present invention is to provide a method of fabricating a TiC-base cermet alloy without the core-rim structure. The above objects of the present invention could be achieved by employing a conventional sintering process (vacuum sintering) of (Ti,TM)C carbide obtained from a mechano-chemical synthesis (high energy ball-milling) from milling the powders of Ti, TM, Ni and Co metals.

Abstract: A rotary incubation station for an automated analyzer is provided. The rotary incubation station includes a platform, a circular ring-shaped outside rotary wheel having a plurality of nesting locations for washing and reading vessels, and a circular disc-shaped inside rotary wheel having a plurality of nesting locations for incubation and storage of vessels. The rotary incubation station also includes a spur gear mechanism for rotating the outside and inside rotary wheels, including spur gear drivers respectively engaged with spur gear teeth of the outside and inside rotary wheel, providing accurate control of the rotation of the outside and inside rotary wheels.

Abstract: An automated slide stainer with slides mounted in a horizontal position on a rotary carousel. Reagents and rinse liquids are automatically dispensed onto tissue sections or cells mounted on slides for the purpose of performing chemical or immunohistochemical stains. The rinse liquids are removed by an aspiration head connected to a source of vacuum. Individual slides or groups of slides are supported on flat heating stations for heating to individual temperatures. Temperature control electronics on the carousel are controlled by a user interface off of the carousel.

Abstract: An apparatus is provided for testing fluid samples includes a sensor, which can be light source, directed to a flow cell and a photo sensor for detecting a light beam reflected from the flow cell. The photo sensor monitors the fluid in the flow cell by sensing the reflected light beam from the flow cell, thereby monitoring the test.

Abstract: An apparatus for handling biopsy specimens comprises a transfer part, a slide displaceable in a groove of said transfer part, preparation plates for the reception of biopsy specimens, and a shifter part that serves to introduce the biopsy specimens into the preparation plates. The empty preparation plates are positioned at a predetermined point in the groove of the transfer part, and the shifter part is placed onto the transfer part above the preparation plates. The biopsy specimens are then introduced into the specimen well of a preparation plate by manually actuated instruments or by means of a stream of fluid. The filled preparation plate is displaced back in the groove of the transfer part using the slide, and is transferred into a specimen holder prepared for it.

Abstract: A piezoelectrically controllable microfluid actor system, comprising a planar substrate which has at least one cavity on at least one side and has at least one passage which has an aperture in the cavity, and at least one diaphragm which has its border mounted on one side of the substrate so as to span the cavity, which has at least two superposed and interconnected diaphragm layers of which at least one is an electrically controllable piezoceramic element, and which is adapted to be deflected into the cavity by means of an electric drive.

Abstract: A fluid delivery system including a first substrate having a micro-channel and a well both formed through the first substrate. The fluid delivery system also includes a second substrate and a delivery channel. The second substrate is on the first substrate and the delivery channel is formed between the first and second substrates. The delivery channel provides fluid communication between the micro-channel and the well.

Abstract: In a preferred embodiment, a precious reagent container, including; a horizontally elongated body; a plurality of vertical, aligned reagent wells defined in the body, the reagent wells having a common depth; and a common vertical channel joining the vertical, aligned reagent wells, the common vertical channel having a depth equal to the common depth. A method of using the precious reagent container is also provided.

Abstract: A reactor vessel is provided with a solvent in a supercritical PVT state for use in depositing films on a deposition substrate. A metal organic precursor is dissolved in the supercritical solvent, as is a reaction agent. A chemical reaction deposits a film, such as a metal film on a semiconducting wafer, and reaction byproducts including a ligand ensue from the chemical reaction. Effluent from the reactor vessel is submitted to a precursor-forming agent that reacts with the ligand to rejuvenate the precursor. Alternatively, the precursor-forming agent can be used for point-of-use formation of the precursor with or without recycle of reaction byproducts.

Abstract: There are disclosed a method and a reaction apparatus which can safely and continuously treat/discharge especially a short object to be treated without any direct contact with a gas atmosphere, and which surely/efficiently treats the object with a gas without any uneven treatment. A short object A to be treated is put in a hermetically sealed cylindrical treatment section 1. In the treatment section 1, the object is held in a predetermined position by a first operation piece 11 to be treated with a gas for a predetermined time. Then, the holding by the first operation piece is released to move the object A by a desired distance. Subsequently, the object is held in a predetermined position by a second operation piece 12 to be treated again with the gas for a predetermined time, and then a treated object A1 is discharged. This discharged treated object A1 is conveyed to the outside of the apparatus.

Abstract: An apparatus and continuous process for the conversion of one solid iron compound to another solid iron compound in a heterogeneous suspension wherein the suspension is formed by dispersing a solid starting iron compound in a liquid that is continuously fed through one or more agitated conversion vessels under hydrothermal conditions and converted to a solid product iron compound having different physical, chemical, or structural properties from the solid starting iron compound.

Abstract: A method for reducing the amount of mercury affixed to a sorbent and/or fly ash is disclosed. The method includes the steps of providing an amount of sorbent and/or fly ash wherein at least a portion of the amount of sorbent and/or fly ash has particulates having mercury compounds affixed to the particulates; and exposing the amount of sorbent and/or fly ash to heated flowing air until mercury compounds are liberated from at least some of the particulates. Preferably, the amount of sorbent and/or fly ash is maintained in the heated flowing air until the sorbent reaches a temperature of at least 700° F. (372° C.). When the sorbent is activated carbon, it is preferred that the amount of sorbent and/or fly ash is maintained in the heated flowing air until the activated carbon reaches a temperature in the range of 700° F. (372° C.) to 1000° F. (538° C.).

Abstract: A method of producing metal chlorides is disclosed in which chlorine gas is introduced into liquid Cd. CdCl2 salt is floating on the liquid Cd and as more liquid CdCl2 is formed it separates from the liquid Cd metal and dissolves in the salt. The salt with the CdCl2 dissolved therein contacts a metal which reacts with CdCl2 to form a metal chloride, forming a mixture of metal chloride and CdCl2. After separation of bulk Cd from the salt, by gravitational means, the metal chloride is obtained by distillation which removes CdCl2 and any Cd dissolved in the metal chloride.

Abstract: A method for synthesizing aluminum nitride is disclosed, wherein an ignition agent is formed by mixing an azide powder (such as sodium azide; NaN3) and aluminum powder, and is paved on an ignition portion of a reactant-containing body having a plurality of ratios of aluminum to a diluent, wherein the content of the diluent is gradually increased in accordance with the propagation direction of combustion wave generated in the combustion synthesis process. The method for synthesizing aluminum nitride is to ignite the ignition agent located in the ignition portion of the reactant-containing body under an ambience in which the pressure is less than 1 atm, and to introduce nitrogen gas as the nitrogen source into the reaction chamber after ignition.

Abstract: A method of transforming a carbon single wall nanotube (SWNT) is provided. The method comprises exposing the SWNT to light having a power sufficient to ignite or reconstruct the SWNT such that the SWNT is ignited or reconstructed by the exposure to the light.

Abstract: The invention concerns a method for producing post-treated carbon black, where the carbon black is fluidized in the fluidized bed while adding fluidizing agents and brought into contact with a post-treatment agent.

Abstract: Granular secondary particles of a lithium-manganese composite oxide suitable for use in non-aqueous electrolyte secondary batteries showing high-output characteristics which are granular secondary particles made up of aggregated crystalline primary particles of a lithium-manganese composite oxide and have many micrometer-size open voids therein with a defined average diameter and total volume of open voids. A process for producing the granular secondary particles which includes spray-drying a slurry of at least a manganese oxide, a lithium source, and an agent for open-void formation to thereby granulate the slurry and then calcining the granules.

Abstract: The present invention is a method of increasing particle surface area and decreasing the concentration of over-sized particles in a process for making metal oxide particles, particularly nanoparticle TiO2, in an inlet-fed, plug flow, plasma reactor by vapor phase reaction of titanium tetrachloride and oxygen in the presence of a source of hydrogen to form titanium dioxide particles.

Abstract: A method for the production of aluminum from bauxites containing aluminum monohydate of the diaspore or boehmite type which may contain more than 1.5% by weight of calcium carbonates. The ore is digested by producing feeding a suspension produced from milled bauxite ore and concentrated aluminate liquor to a plant with a series of autoclaves and a series of regulators supplying tubular reheaters across the autoclaves with steam. The suspension first travels across the series of autoclaves, and on exiting, the digestion of the ore is practically complete, and the suspension then travels across the series of regulators. The condensation water from the steam coming from the regulator and feeding the reheater is collected in a purge pot. Within the series of regulators, the suspension is diluted on entering a regulator with the water coming from the condensation of the steam from one or several upstream regulators.

Abstract: A method for treating respiratory disorders comprises administering to a patient a pharmaceutical aerosol formulation comprising: (i) a compound of formula (I) or a salt or solvate thereof, wherein: n represents an integer 1 to 6; N represents an integer 1 to 15; R1 represents —(CO)xC1-9 alkyl or —(CO)xC1-9 fluoroalkyl, which fluoroalkyl moiety contains at least 1 fluorine atom and not more than 3 consecutive perfluorocarbon atoms wherein x represents 0 or 1; and R2 and R3 independently represent C1-3alkyl or hydrogen, (ii) at least one medicament, and (iii) at least one propellant.

Abstract: A microparticle contains a cross-linked protein shell, and a surface coating.

Abstract: The invention features substantially pure nucleic acid sequences encoding wild-type or mutant serotonin reuptake transporter (SERT) polypeptides, as well as the polypeptides themselves. The invention also features methods for identifying modulators of the biological activity of a SERT and for identifying if such a modulator has a secondary target. In addition, the invention features methods for treating a condition in a subject.

Abstract: The present invention is directed to novel polypeptides having sequence identity with IL-17 and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders.

Abstract: The invention concerns the use of novel agents including cell death, and in particular, an agent for overexpression of the PML protein on nuclear bodies, combined with interferons, to induce the death of undesirable cells and simulate an immune reaction.

Abstract: The present invention relates to the use of lactic acid bacteria capable of adhering to the mucosa of the intestine and especially colonizing it for the prevention of peritonitis. In particular, the present invention relates to the use of such lactic acid bacteria for the prevention of peritonitis caused by cirrhosis of the liver. Specifically, the present invention relates to a method for preventing peritonitis in a patient in need of such prevention. This method includes administering to the patient a lactic acid bacterium that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier. The invention also relates to a peritonitis preventing composition of a lactic acid bacterium that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier. The carrier is preferably a food or pharmaceutical composition.

Abstract: According to the present invention, a series of genes are identified in Group B Streptococcus, the products of which may be located on the outer surface of the organism. The genes, or functional fragments thereof, may be useful in the preparation of therapeutics, e.g. vaccines for the immunization of a patient against microbial infection.

Abstract: The use of G class immunoglobulins, particularly immunoglobulins for intravenous use or for intramuscular use to produce a medicine for the local therapeutic treatment of dermatitis, particularly acne, contact dermatitis, atopic dermatitis, eczema and ichthyosis, psoriasis papulosquamous dermatopathies (seborrehic dermatitis, erythrodermia, etc.), as well as fungus, parasite, bacterium and virus infection dermatitis is disclosed. The pharmaceutical composition containing G class immunoglobulins suitable for topical application for the treatment of dermatitis is also disclosed.

Abstract: Disclosed are gel-based cosmetic and wound-healing formulations, methods for making said formulations, and a method for simultaneously treating and concealing injuries to human skin. In one exemplary embodiment, the cosmetic and wound-healing formulation comprises live yeast cell extract, pigment, and a gel.

Abstract: The present invention provides vaccine compositions of attenuated dengue virus. More specifically, the attenuated virus is produced by serial passage in PDK cells. The invention also provides methods for stimulating the immune system of an individual to induce protection against all four dengue virus serotypes by administration of attenuated dengue-1, dengue-2, dengue-3, and dengue-4 virus.

Abstract: The present invention relates to a vaccine composition comprising VLPs containing L1 proteins or functional L1 protein derivatives from HPV 16, HPV 18, HPV 31 and HPV 45 genotypes.

Abstract: The present invention provides a protective formulation that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes. The formulation comprises a protective amount of live MG strain K5054 or derivatives thereof in a pharmaceutically acceptable carrier. A vaccine that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes is also presented. Methods for administering the formulation and vaccine are also presented.

Abstract: The present invention provides novel, isolated, tumor-associated antigens, and methods for identifying such antigens in a biological sample, and of screening for the presence of such an antigen in a biological specimen, wherein the tumor antigen identified reacts with serum from a subject treated with a vaccine comprising a cytokine and proliferation-incompetent tumor cells which express the tumor-associated antigen. Also provided are kits for carrying out the methods of the invention.

Abstract: The present invention comprises a composition, method of enhancing potency and method of delivering corticosteroids in a vehicle comprising at least two penetration enhancers, and solvents and emulsifiers. The propylene glycol and penetration enhancers are present in ratio to the total of the propylene glycol, penetration enhancers, and solvents and emulsifiers of at least about 0.70.

Abstract: The invention relates to a revitalizing active complex for the skin and cosmetic products produced thereby. Said active complex for the skin consists of between 0.5 and 9 wt. % of creatine or a creatine derivative, between 0.1 and 40 wt. % of water-soluble glycogen, between 0.1 and 10 wt. % of a phospholipid, and between 0.1 and 5 wt. % of a cosmetically acceptable gel, water making up the remainder of the 100 wt. %, said mixture of creatine, glycogen and phospholipid being homogeneously distributed in the aqueous gel.

Abstract: A personal care or cosmetic product composition that includes from about 0.1% to about 99% of at least one ester of alkoxylated aromatic alcohol and fatty carboxylic acid, and from about 0.1% to 60% of at least one functional ingredient is provided. The functional ingredients in the composition may include active ingredients and additional ingredients. Especially suitable active ingredients are sunscreen active ingredients and antiperspirant active ingredients. Preferred compositions are sunscreen product formulations and antiperspirant products. In one preferred embodiment, the composition further includes at least one cyclomethicone compound present in the amount of from about 1% to 99% by weight of the composition. A method of improving the protection of human or animal skin or hair from radiation and a method of improving the protection of human or animal skin or hair from perspiration are also provided.

Abstract: A hydrocephalus shunt having an anti-inflammatory coating applied to at least the outside surface of the ventricular catheter. Such coatings are also applicable to other medical devices or implants.

Abstract: Coatings for implantable medical devices and methods for fabricating the same are disclosed. The coatings include a region containing a polycationic peptide, such as, for example, the polycationic peptide known as R7.

Abstract: The present invention provides biocompatible vesicles comprising semi-permeable, thin-walled encapsulating membranes which are formed in an aqueous solution, and which comprise one or more synthetic super-amphiphilic molecules. When at least one super-amphiphile molecule is a block copolymer, the resulting synthetic vesicle is termed a “polymersome.” The synthetic, reactive nature of the amphiphilic composition enables extensive, covalent cross-linking of the membrane, while maintaining semi-permeability. Cross-linking of the polymer building-block components provides mechanical control and long-term stability to the vesicle, thereby also providing a means of controlling the encapsulation or release of materials from the vesicle by modifying the composition of the membrane. Thus, the encapsulating membranes of the present invention are particularly suited for the reliable, durable and controlled transport, delivery and storage of materials.

Abstract: Disclosed is a device which employs a chemically sensitive cantilever hingably attached to a capsule. The cantilever functions as a switch which regulates the flow of particles into and/or out of the capsule.

Abstract: The pharmaceutical dosage form consists of a plurality of units containing a benzimidazole compound labile in an acid medium as the active principle, each unit being comprised of an inert core, a layer containing the active principle and an intermediate layer. These units, mixed with compression excipients, compressed and coated with an enteric coating, provide a tableted pharmaceutical dosage form suitable for oral administration for preventing and treating disorders related to abnormal secretion of gastric acid.

Abstract: Bacterial infections may be treated using a high dosage regimen of amoxicillin and potassium clavulanate. Preferably, the dosage is provided by a bilayer tablet.

Abstract: A process for the preparation of a particulate material by a controlled agglomeration method, i.e. a method that enables a controlled growth in particle size. The method is especially suitable for use in the preparation of pharmaceutical compositions containing a therapeutically and/or prophylactically active substance which has a relatively low aqueous solubility and/or which is subject to chemical decomposition. The process comprising i) spraying a first composition comprising a carrier, which has a melting point of about 5° C. or more which is present in the first composition in liquid form, on a second composition comprising a material in solid form, the second composition having a temperature of at the most a temperature corresponding to the melting point of the carrier and/or the carrier composition and ii) mixing or others means of mechanical working the second composition onto which the first composition is sprayed to obtain the particulate material.

Abstract: Lanolin-free lanolin substitute compositions comprising: A) from about 50 to about 95% by weight, of at least one plant sterol fatty acid ester; B) from about 1 to about 10% by weight, of at least one polyglyceryl di-polyhydroxy fatty acid ester; C) from about 1 to about 10% by weight, of at least one polyglyceryl di-fatty acid ester; and D) from about 0.25 to about 2% by weight of at least one glyceryl fatty acid ester.

Abstract: The present invention relates to animal feed additives, which additives comprise a monocomponent xylanase derived from a strain of Byssochlamus, Chaetomium, Humicola, Malbranchea, Mucor, Myceliophthora, Paecilomyces, Talaromyces, Thermoascus, or Thielavia. In other aspects, the invention relates to monocomponent xylanase preparations, DNA constructs, recombinant expression vectors, host cells, and methods of producing monocomponent xylanase preparations.

Abstract: A container for condiments, e.g., nuts and nuggets of chocolates, comprising a cylinder with a bottom side mountable on the top of a standard cup/can. In one version, a bottom side is displaced from the bottom edge of the cylinder to form a skirt on the bottom edge of the cylinder. The skirt has an interior lip dimensioned such that the container “snaps” onto the rim of a beverage can or cup. In another version, the cylinder and cup/can are telescoped into a sleeve. The top edge of cap/cup is adhered to a cover that is peeled back for access to the condiments. In another version, a partial lid is interposed between the cover and top rim of the cylinder. A drinking straw is inserted from the above the cover, through the container into the cup/can.

Abstract: A concentrated cherry nutraceutical is prepared by extracting cherry juice from cherries and repeatedly freezing the cherry juice and separating cherry juice of increased concentration while maintaining the juice at freezing conditions.